ISRCTN84445406已完成未知
STHLM3 - Prostate cancer diagnostic randomized trial
Karolinska Institutet (Sweden)0 个研究点目标入组 140,000 人开始时间: 2013年1月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 140,000
研究概览
简要总结
2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26563502 results 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36185581/ (added 04/10/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •All men between 50 and 69 years of age who have a permanent postal address in Stockholm County Council or Region Gotland (N=260,000) will be asked whether they would like to take part in STHLM3.
排除标准
- •Diagnosed with prostate cancer
研究者
相似试验
已完成
不适用
STHLM3 - Prostate Cancer Diagnostic TrialProstate CancerNCT03639649Karolinska Institutet58,818
已完成
不适用
STHLM3-MR: Comparing Standard With Targeted Prostate BiopsiesProstate CancerNCT02788825Karolinska Institutet687
进行中（未招募）
不适用
Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion BiopsiesProstate CancerNCT03377881Karolinska Institutet12,750
已完成
不适用
Prostate cancer screening trial using imagingProstate cancerCancerISRCTN43502108Imperial College London408
进行中（未招募）
3 期
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate CancerProstate CancerNCT03531099Hospices Civils de Lyon108